NFKB1 and metabolic dysfunction-associated steatotic liver disease: Carvedilol and nicorandil counteracted these effects by lowering NF-kb expression and malondialdehyde (MDA) levels and increasing GSH content and endothelial Nitric oxide synthases (eNOS) expression, proving that vasodilatation could ameliorate MASLD.